PAR-25-281-Full-Announcement.html

This document is a Notice of Funding Opportunity (NOFO) for the Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) grant, solicitation number PAR-25-281. The purpose is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders during the menopause transition, in order to identify targets for future treatment interventions.

The grant is funded by the Department of Health and Human Services National Institutes of Health, specifically the National Institute of Mental Health (NIMH) and the NIH Office of Research on Women's Health. Eligible applicant types include independent school districts, tribal governments, non-profits, small businesses, higher education institutions, and other organizations. The funding will support hypothesis-driven, comprehensive research on the neurobiology and mechanisms underlying mood and psychosis symptoms during the menopause transition. Review criteria will focus on the proposed work's comprehensiveness in addressing these areas.